Center for Molecular Medicine Report issue

Government Phase 1 Phase 2

Organization Overview

First Clinical Trial
1995
NCT00002689
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (3)

fluorouracil (efudex) (1 trial)

niclosamide (nicloside) (1 trial)

urea (1 trial)

Drugs in Phase 1 Trials (2)

cisplatin (platinol) (1 trial)

vinblastine (velban) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Colorectal Neoplasms (Phase 2)

Lung Neoplasms (Phase 1)

Pancreatic Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 5